PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KESTREL INVESTMENT MANAGEMENT CORP | 1,465,000 | $3,853,000 | 1.56% |
SMH CAPITAL ADVISORS INC | 93,708 | $246,000 | 0.42% |
West Family Investments, Inc. | 627,800 | $1,651,000 | 0.39% |
KENNEDY CAPITAL MANAGEMENT LLC | 7,082,858 | $18,628,000 | 0.35% |
ARMISTICE CAPITAL, LLC | 1,800,000 | $4,734,000 | 0.28% |
BRANDES INVESTMENT PARTNERS, LP | 3,936,719 | $10,354,000 | 0.23% |
ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $38,000 | 0.13% |
Zebra Capital Management LLC | 74,695 | $196,000 | 0.09% |
Connor, Clark & Lunn Investment Management Ltd. | 5,968,105 | $15,696,000 | 0.09% |
CREDIT AGRICOLE S A | 471,644 | $1,240,000 | 0.06% |